Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06356168 · ClinicalTrials.gov registry record · NA
Virtual Reality in End Stage Kidney Disease
A NA study, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06356168: Recruiting NA study, sponsored by University of Pennsylvania.
NCT06356168 is a NA study that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06356168, a NA study, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Interventions
- BEHAVIORAL Social Virtual Reality
- BEHAVIORAL Individual Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06356168
The ClinicalTrials.gov registry entry for NCT06356168 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Social Virtual Reality is the first listed.
NCT06356168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06356168 about?
NCT06356168 is a clinical study titled "Virtual Reality in End Stage Kidney Disease". The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for...
What is the current status of trial NCT06356168?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03-30. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT06356168?
The interventions under investigation include: Social Virtual Reality (BEHAVIORAL), Individual Virtual Reality (BEHAVIORAL).
Who is sponsoring clinical trial NCT06356168?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.